SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-039510
Filing Date
2023-02-15
Accepted
2023-02-14 19:47:03
Documents
12
Period of Report
2023-02-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d459776d8k.htm   iXBRL 8-K 23554
  Complete submission text file 0001193125-23-039510.txt   141421

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA xbit-20230203.xsd EX-101.SCH 2549
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20230203_lab.xml EX-101.LAB 17320
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20230203_pre.xml EX-101.PRE 10897
6 EXTRACTED XBRL INSTANCE DOCUMENT d459776d8k_htm.xml XML 3370
Mailing Address 5217 WINNEBAGO LANE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37347 | Film No.: 23632973
SIC: 2834 Pharmaceutical Preparations